
Please try another search
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Name | Age | Since | Title |
---|---|---|---|
Joseph S. Lacob | 69 | 1997 | Independent Director |
Nimesh S. Shah | - | - | Board Observer |
Rakhi Kumar | 45 | 2021 | Independent Director |
Joel D. Becker | 57 | 2023 | CEO, President & Director |
Lisa M. Andrade | 53 | 2021 | Independent Director |
Uri Geiger | 57 | 2023 | Independent Director |
R. Scott Huennekens | 61 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review